Saving an average $60,000 per stroke patient

Rapid diagnostic test for detecting large vessel occlusion in acute ischemic stroke patients using brain biomarkers. Enables fast clinical validation and patient stratification to guide immediate intervention decisions in stroke management.

A point-of-care diagnostic solution powered by advanced blood-based biomarkers for brain injuries. LVOCheck is designed for the selection and triage of large vessel occlusion (LVO) stroke patients to identify those requiring rapid treatment. The platform utilizes proprietary Software as a Medical Device technology to differentiate between ischemic and haemorrhagic stroke and detect mild traumatic brain injury.

Rapid diagnostic tests that produce accurate results in minutes for point-of-care and clinical settings to enable faster diagnoses and improved patient outcomes.

Point-of-care rapid diagnostic tests delivering accurate results within minutes. Enables faster diagnoses and better-informed clinical treatment decisions across multiple disease areas.

Lumi Go is a camera-based lateral flow reader for rapid optical analysis of diagnostic test strips across healthcare, food, and water quality applications. The device provides automated result interpretation with customizable algorithms and integrates with laboratory information systems via secure cloud connectivity for data management and regulatory compliance.

A microfluidic-based cardiovascular diagnostic test system providing lab-level accuracy for point-of-care testing. Designed for quick cardiovascular assessment using the mLabs® platform technology.

Laser-based diagnostic platform designed for rapid, multiplexed lateral flow testing with significantly reduced manufacturing costs. The technology provides sensitive and scalable point-of-care diagnostic capabilities for various clinical applications.

A rapid biochemical test that differentiates between ischemic stroke and intracranial hemorrhage within the first 4 hours from symptom onset. The test uses a combination of biomarkers to provide accurate diagnosis for stroke subtype determination, enabling rapid decision-making at point-of-care settings including ambulances and primary hospitals. This allows for timely initiation of specific treatment protocols such as reperfusion therapies.

Automated system for real-time cardiovascular metric measurement and assessment, including carotid plaque detection and evaluation. Significantly improves diagnostic efficiency and accuracy in cardiovascular risk stratification.

Rapid diagnostic test kits for biomarker detection using lateral flow technology. Customizable components enable development of point-of-care assays for clinical and laboratory applications. Provides quick results with reliable accuracy for infectious disease, cardiac, and immunological testing.

AI-powered cardiovascular risk assessment solution that analyzes single retinal photographs to predict cardiovascular disease risk. Provides results comparable to CT coronary angiography without radiation exposure, completed in minutes with instant, accurate results for clinical decision-making.

Epigenetic-based diagnostic test for early detection of cerebrovascular disease and stroke risk. Developed in collaboration with Beijing Tiantan Hospital, this test supports stroke prevention initiatives. The product integrates findings from a large-scale stroke cohort study.